Christi Shaw, President of Lilly Bio-Medicines, provides a master class on the impact of migraines on the home and the economy. She visited the ICE House for the release of Emgality, a new preventative treatment of migraines in adults and details the journey from medical research breakthrough to FDA approval. Christi shared her thoughts on improving the industry, drug prices, and what she has learned along the way about treating patients and providing value.

 

Inside the ICE House: https://www.theice.com/podcast/inside-the-ice-house